Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Neptune Technologies & Bioresources (NEPT) Share Price
Media stories about Neptune Technologies & Bioresources (NASDAQ:NEPT) (TSE:NTB) have trended somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Neptune Technologies & Bioresources earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave headlines about the biotechnology company an impact score of 45.7260241827564 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Shares of Neptune Technologies & Bioresources (NEPT) traded up 2.4450% during mid-day trading on Thursday, hitting $0.8799. The stock had a trading volume of 189,789 shares. The firm has a market capitalization of $69.20 million, a PE ratio of 13.5369 and a beta of 0.83. Neptune Technologies & Bioresources has a 1-year low of $0.70 and a 1-year high of $1.53. The stock’s 50-day moving average is $0.85 and its 200-day moving average is $0.95.
TRADEMARK VIOLATION WARNING: This piece of content was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/07/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-neptune-technologies-bioresources-nept-share-price.html.
About Neptune Technologies & Bioresources
Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.
Receive News & Stock Ratings for Neptune Technologies & Bioresources Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioresources Inc and related stocks with our FREE daily email newsletter.